TY - JOUR
T1 - Allergen immunotherapy
T2 - Therapeutic vaccines for allergic diseases - A WHO position paper
AU - Bousquet, Jean
AU - Lockey, Richard
AU - Malling, Hans Jorgen
AU - Alvarez-Cuesta, Emilio
AU - Canonica, Giorgio W.
AU - Chapman, Martin D.
AU - Creticos, Peter J.
AU - Dayer, Jean Michel
AU - Durham, Stephen R.
AU - Demoly, Pascal
AU - Goldstein, Robert J.
AU - Ishikawa, Takeru
AU - Ito, Koji
AU - Kraft, Dietrich
AU - Lambert, Paul Henri
AU - Løwenstein, Henig
AU - Müller, Ulrich
AU - Norman, Philip S.
AU - Reisman, Robert E.
AU - Valenta, Rudolph
AU - Valovirta, Erkka
AU - Yssel, Hans
N1 - Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 1998
Y1 - 1998
N2 - The World Health Organization and various allergy, asthma, and immunology societies throughout the world met on January 27 through 29, 1997, in Geneva, Switzerland to write guidelines for allergen immunotherapy. Over the ensuing year, the editors and panel members reached a consensus about the information to include in the WHO position paper "Allergen immunotherapy: Therapeutic vaccines for allergic diseases." The historical term allergen extract was changed to allergen vaccine to reflect the fact that allergen vaccines are used in medicine as immune modifiers. The document summarizes the scientific literature and rationale for the appropriate use of such therapy to treat allergic rhinoconjunctivitis, allergic asthma, and Hymenoptera hypersensitivity. It also includes recommendations to improve safety, discusses new techniques being developed that may result in better efficacy and less risk, and offers recommendations for areas of additional and necessary research.
AB - The World Health Organization and various allergy, asthma, and immunology societies throughout the world met on January 27 through 29, 1997, in Geneva, Switzerland to write guidelines for allergen immunotherapy. Over the ensuing year, the editors and panel members reached a consensus about the information to include in the WHO position paper "Allergen immunotherapy: Therapeutic vaccines for allergic diseases." The historical term allergen extract was changed to allergen vaccine to reflect the fact that allergen vaccines are used in medicine as immune modifiers. The document summarizes the scientific literature and rationale for the appropriate use of such therapy to treat allergic rhinoconjunctivitis, allergic asthma, and Hymenoptera hypersensitivity. It also includes recommendations to improve safety, discusses new techniques being developed that may result in better efficacy and less risk, and offers recommendations for areas of additional and necessary research.
UR - http://www.scopus.com/inward/record.url?scp=0031736285&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031736285&partnerID=8YFLogxK
U2 - 10.1016/s0091-6749(98)70271-4
DO - 10.1016/s0091-6749(98)70271-4
M3 - Article
C2 - 9802362
AN - SCOPUS:0031736285
SN - 0091-6749
VL - 102
SP - 558
EP - 562
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 4 II
ER -